Risk of Ventricular Arrhythmia and Sudden Cardiac Death Associated with Combined Use of Antipsychotics and SSRIs
By
Hsiu-Ting Chien
Shu-Wen Lin
Te-Jung Kung
Chi-Chuan Wang
Yaa-Hui Dong
Tzung-Jeng Hwang
Fang-Ju Lin
Sengwee Toh
April 9, 2026
Clinical Scorecard: Risk of Ventricular Arrhythmia and Sudden Cardiac Death Associated with Combined Use of Antipsychotics and SSRIs
At a Glance
Category Detail
Condition Ventricular Arrhythmia and Sudden Cardiac Death Key Mechanisms Inhibition of rapid delayed rectifier potassium current leading to QT prolongation and potential torsades de pointes. Target Population Adults aged 18 years or older with psychotic disorders initiating outpatient antipsychotics. Care Setting Outpatient settings, including both commercial and Medicare supplemental insurance in the US and universal health care in Taiwan.
Key Highlights
Antipsychotics consistently associated with higher sudden death rates compared to nonuse. Mixed evidence for SSRIs, with some studies indicating modest increased risk, particularly with citalopram. Concurrent use of SSRIs and antipsychotics is common despite potential arrhythmia risks. Pharmacokinetic interactions may elevate exposure to QT-prolonging drugs. Limited evidence on arrhythmic outcomes with concomitant use of SSRIs and antipsychotics. Guideline-Based Recommendations
Diagnosis
Monitor for ventricular arrhythmia and sudden death in patients using antipsychotics and SSRIs. Management
Consider combination therapy for psychotic depression, but assess risks of QT prolongation. Monitoring & Follow-up
Regularly evaluate QTc intervals in patients receiving concurrent treatment. Risks
Increased risk of medication-induced ventricular arrhythmia or sudden death due to drug interactions. Patient & Prescribing Data
Adults with psychotic disorders newly initiating outpatient antipsychotics.
SSRI initiation may be beneficial but requires careful monitoring for arrhythmia risk.
Clinical Best Practices
Evaluate individual patient risk factors for arrhythmia before prescribing. Educate patients about the signs and symptoms of arrhythmia and sudden cardiac events. Utilize a multidisciplinary approach to manage patients on combined therapies. References
